Conducting collaborative research locally, nationally and globally.
You are viewing an old version of this page. View the current version.
Compare with Current View Page History
« Previous Version 11 Next »
de Oliveira, C., Gatov, E., Rosella, L., Chen, S., Strauss, R., Azimaee, M., Paterno, E., Guttmann, A., Ministry of Children, Community Social Services & Ices Working Group 2022. Describing the linkage between administrative social assistance and health care databases in Ontario, Canada. Int J Popul Data Sci, 7(1):1689.
de Oliveira, C., Kouyoumdjian, F.G., Iwajomo, T., Jones, R., Simpson, A.I.F. & Kurdyak, P. 2022. Health care costs of individuals with chronic psychotic disorders who experience incarceration in Ontario. Psychiatr Serv, 73(7):760-767.
de Oliveira, C., Macpherson, A., Hepburn, C.M., Huang, A., Strauss, R., Liu, N., Fiksenbaum, L., Pageau, P., Gomez, D. & Saunders, N.R. 2022. Healthcare utilization and costs following non-fatal powdered and non-powdered firearm injuries for children and youth. European Journal of Pediatrics, 181(6):2329-2342.
de Oliveira, C., Mondor, L., Wodchis, W.P. & Rosella, L.C. 2022. Looking beyond administrative health care data: The role of socioeconomic status in predicting future high-cost patients with mental health and addiction. Can J Psychiatry, 67(2):7067437211004882.
Barry, R., Rehm, J., de Oliveira, C., Gozdyra, P., Chen, S. & Kurdyak, P. 2022. Rurality as a risk factor for attempted suicide and death by suicide in Ontario, Canada. Can J Psychiatry, 67(9):679-689.
Dai, W.F., Beca, J.M., Nagamuthu, C., Liu, N., de Oliveira, C., Earle, C.C., Trudeau, M. & Chan, K.K.W. 2022. Cost-effectiveness analysis of Pertuzumab with Trastuzumab in patients with metastatic breast cancer. JAMA Oncol, 8(4):597-606.
Dai, W.F., Beca, J.M., Nagamuthu, C., Liu, N., de Oliveira, C., Earle, C.C., Trudeau, M., Mercer, R.E. & Chan, K.K.W. 2022. Comparative effectiveness and safety of pertuzumab and trastuzumab plus chemotherapy vs trastuzumab plus chemotherapy for treatment of metastatic breast cancer. JAMA Netw Open, 5(2):e2145460.
Dai, W.F., de Oliveira, C., Blommaert, S., Pataky, R.E., Tran, D., Aurangzeb, Z., Kendell, C., Folkins, C., Somayaji, C., Dowden, J., Cheung, W., Strumpf, E., Beca, J.M., McClure, C., Urquhart, R., McDonald, J.T., Alvi, R., Turner, D., Peacock, S., Denburg, A., Mercer, R.E., Munoz, C., Parmar, A., Tadrous, M., Takhar, P., Chan, K.K.W. & On Behalf Of The CanREValue Collaboration 2022. Mapping Canadian data assets to generate real-world evidence: lessons learned from Canadian real-world evidence for value of cancer drugs (CanREValue) Collaboration's RWE Data Working Group. Curr Oncol, 29(3):2046-2063.
Davies, S.J., Rudoler, D., de Oliveira, C., Huang, A., Kurdyak, P. & Iaboni, A. 2022. Comparative safety of chronic versus intermittent benzodiazepine prescribing in older adults: A population-based cohort study. J Psychopharmacol:2698811211069096.
Essue, B.M., Oliveira, C., Bushnik, T., Fung, S., Hwee, J., Sun, Z., Navas, E.G., Yong, J.H.E. & Garner, R. 2022. The burden of health-related out-of-pocket cancer costs in Canada: A case-control study using linked data. Curr Oncol, 29(7):4541-4557.
Fuller, A.E., Zaffar, N., Cohen, E., Pentland, M., Siddiqi, A., Vandermorris, A., Van Den Heuvel, M., Birken, C.S., Guttmann, A. & de Oliveira, C. 2022. Cash transfer programs and child health and family economic outcomes: a systematic review. Can J Public Health, 113(3):433-445.
Garaszczuk, R., Yong, J.H.E., Sun, Z. & de Oliveira, C. 2022. The economic burden of cancer in Canada from a societal perspective. Curr Oncol, 29(4):2735-2748.